B1
|
Yoshitake et al. 1995 [11]; Hisayama (n = 828)
|
73.6 ± 5.9a
|
7
|
Per 1 SD increase (23 mmHg)
| | | |
1.6 (1.2, 2.2)
b
| |
1.0 (0.7, 1.4)b
|
B1
|
Launer et al. 2000 [27]; HAAS (n = 3,734)
|
52.7 ± 4.7 (men)
|
27
|
Untreated SBP ≥160
|
227
|
2,295
|
4.85 (1.99, 11.83)
c
|
10.68 (3.49, 32.64)
c
|
1.75 (0.58, 5.29)c
|
-
|
| | | |
Untreated DBP ≥90
|
132
|
1,128
|
4.32 (1.72, 10.85)
c
|
4.61 (1.61, 13.19)
c
|
2.78 (0.54, 14.25)c
|
6.6 (2.0, 21.4)
c
|
B1
|
Kivipelto et al. 2002 [35] (n = 2,293)
|
50.2 ± 6.0
|
21
|
SBP 140-159
|
-
|
-
|
1.9 (0.8, 4.8)d
| | |
1.6 (0.7, 4.2)d
|
| | | |
SBP = 160
|
-
|
-
|
2.8 (1.1, 7.2)
d
| | |
2.6 (1.1, 7.2)
d
|
| | | |
DBP 90-94
|
-
|
-
|
1.4 (0.5, 3.6)d
| | |
1.2 (0.4, 3.3)d
|
| | | |
DBP ≥ 90
|
-
|
-
|
2.3 (1.1, 5.1)
d
| | |
2.0 (0.9, 4.6)d
|
B1
|
Qiu et al. 2010 [2]; Kungsholmen (n = 1,270)
|
81.5 ± 5.0
|
5.1
|
SBP 140-159
|
127
|
278
|
1.22 (0.89, 1.68)e
| | |
1.47 (1.02, 2.12)
e
|
| | | |
SBP ≥ 160
|
127
|
351
|
1.49 (0.94, 2.37)e
| | |
1.84 (1.06, 3.18)
e
|
B1
|
Rönnemaa et al. 2011 [3]; Uppsala (n = 2,268)
|
49.6 ± 0.6
|
29
|
Per 1 SD increase (18 mmHg)
| | |
1.2 (1.0, 1.3)
f
|
1.3 (1.1, 1.6)
f
|
1.1 (1.0, 1.2)
f
|
1.0 (0.8, 1.2)f
|
| |
71.0 ± 0.6
|
13
|
Per 1 SD increase (19 mmHg)
| | |
1.2 (1.0, 1.3)
f
|
1.6 (1.2, 2.1)
f
|
1.1 (1.0, 1.3)
f
|
1.0 (0.8, 1.2)f
|
B2
|
Shah et al. 2006 [28]; ROS (n = 824)
|
75 ± 7
|
6.0
|
Per 1 mmHg increase in SBP
| | | | | |
0.995 (0.986, 1.004)g
|
| | | |
Per 1 mmHg increase in SBP
| | | | | |
1.000 (0.985, 1.015)g
|